Tag Archives: drug safety

Exploring Vaccination Safety

As vaccine research and development continues to grow, so does the debate regarding vaccination safety and best practices. Our reports review the clinical and biological evidence regarding immunization safety.

The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies

Vaccines are among the most safe and effective public health interventions to prevent serious disease and death. Because of the success of vaccines, most Americans today have no firsthand experience with such devastating illnesses as polio or …


Adverse Effects of Vaccines: Evidence and Causality

In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed …


Building a National Capability to Monitor and Assess Medical Countermeasure Use During a Public Health Emergency: Going Beyond the Last Mile: Proceedings of a Workshop

During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to …


Integrating Clinical Research into Epidemic Response: The Ebola Experience

The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two …


Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world’s hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 …


Priorities for the National Vaccine Plan

Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. …


Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint

As a number of diseases emerge or reemerge thus stimulating new vaccine development opportunities to help prevent those diseases, it can be especially difficult for decision makers to know where to invest their limited resources. Therefore, it is …


Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System

SMART Vaccines–Strategic Multi-Attribute Ranking Tool for Vaccines–is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine …


Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework

SMART Vaccines – Strategic Multi-Attribute Ranking Tool for Vaccines – is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine …


Five New Books: Weather Science, Drug Safety, and more

Our usual collection of the new publications to NAP.edu this week includes a number of books on health and medicine, as well as a prepublication on weather. Four of the five new books this week have Free PDFs available to download.

All New Publications This Week

When Weather Matters: Science and Service to Meet Critical Societal Needs (prepublication)

Ethical Issues in Studying the Safety of Approved Drugs: A Letter Report (final)

Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Improving Quality of Care: Workshop Summary (prepublication)

Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (prepublication)

A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program (final)